Karen Schreiber, Eliza Chakravarty, Monika Østensen
Practical Management of the Pregnant Patient with Rheumatic Disease
Karen Schreiber, Eliza Chakravarty, Monika Østensen
Practical Management of the Pregnant Patient with Rheumatic Disease
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
A collection of 70 cases covering pregnancy counselling, the management of disease flares, thromboembolic disease, the management of patients with end organ disease, advice on medications, obstetric complications, infections and the management of rare diseases in women with rheumatic diseases before and during pregnancy as well as post-partum.
Andere Kunden interessierten sich auch für
- Paul McGillHandbook of Rheumatic Diseases in Africa34,99 €
- Immune Reactions and Experimental Models in Rheumatic Diseases59,99 €
- American College of Obstetricians and GynecologistsProlog: Patient Management in the Office, Seventh Edition (Assessment & Critique)207,99 €
- Bashir M. MatataThe Molecular Basis for the Link Between Maternal Health and the Origin of Fetal Congenital Abnormalities: An overview of Association with Oxidative S98,99 €
- Institute Of MedicineThe Role of Environmental Hazards in Premature Birth54,99 €
- Palliative and Serious Illness Patient Management for Physician Assistants102,99 €
- Sean AinsworthNeonatal Formulary137,99 €
-
-
-
A collection of 70 cases covering pregnancy counselling, the management of disease flares, thromboembolic disease, the management of patients with end organ disease, advice on medications, obstetric complications, infections and the management of rare diseases in women with rheumatic diseases before and during pregnancy as well as post-partum.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Hurst & Co.
- Seitenzahl: 240
- Erscheinungstermin: 28. März 2021
- Englisch
- Abmessung: 235mm x 159mm x 15mm
- Gewicht: 401g
- ISBN-13: 9780198845096
- ISBN-10: 019884509X
- Artikelnr.: 59993490
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Hurst & Co.
- Seitenzahl: 240
- Erscheinungstermin: 28. März 2021
- Englisch
- Abmessung: 235mm x 159mm x 15mm
- Gewicht: 401g
- ISBN-13: 9780198845096
- ISBN-10: 019884509X
- Artikelnr.: 59993490
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Dr Karen Schreiber main clinical and research interests are antiphospholipid syndrome and connective tissue diseases in pregnant women. Dr Schreiber is involved in identifying alternative treatment to improve fetal and maternal pregnancy outcomes in pregnant women with antiphospholipid syndrome. Dr Schreiber is an active member of the British Society for Rheumatology (BSR) working groups publishing clinical guidelines with the overall aim to improve the treatment of patients with rheumatic diseases. Dr. Chakravarty is a rheumatologist and epidemiologist with a longstanding clinical and research interest in understanding the interrelationships between pregnancy and underlying rheumatic diseases. She works to identify and mitigate risk factors for adverse pregnancy outcomes and to optimize medical management of chronic rheumatic diseases during pregnancy and the postpartum period in order to maximize outcomes for both mother and infant. Dr. Østensen is a rheumatologist with a special interest in the interaction between pregnancy and the rheumatic diseases. Her research through many years has focussed on reproduction issues of women and men with rheumatic disease; immunology of pregnancy; antirheumatic drugs during pregnancy and breastfeeding. She has established specialized centers at Rheumatology departments in Norway and in Switzerland that counsel and manage patients who plan a family or are pregnant.
* Section One: Counselling
* 1: Monika Østensen: Important points of pre-pregnancy counselling
* Section Two: Patients with pre-pregnancy complications
* 2.1: Andrew James Doyle and Beverley Jane Hunt: Thrombotic
Complications in pregnant patients with rheumatic disease
* 2.2: Roseann O'Doherty and Fionnuala Ní Ainle: Prevention of
postpartum venous thromboembolism (VTE)
* 2.3: Eliza Chakravarty: Pulmonary Arterial Hypertension
* 2.4: Hannah Blakey and Kate Bramham: Advanced renal disease / renal
impairment
* 2.5: Massimo Radin, Karen Schreiber, and Savino Sciascia: Antibodies
as risk factors for adverse maternal and fetal outcomes
* Section Three: Adjustment of therapy before/during pregnancy and
lactation
* 3.1: Monika Østensen and Ian Giles: Disease modifying drugs,
biological drugs and concomitant medications before/during pregnancy
and lactation
* 3.2: Christof Schaefer: Managing a patient exposed to a teratogenic
drug at different stages of pregnancy
* Section Four: Infection during pregnancy
* 4: Maria Rhona G. Bergantin and Sandra V. Navarra: Infection in a
pregnant patient on immunosuppressive treatment
* Section Five: Organ specific flares during pregnancy
* 5: Bonnie L. Bermas and Eliza Chakravarty: Managing Organ Specific
Flares
* Section Six: Obstetric complications in women with autoimmune
diseases
* 6: D. Ware Branch: Pregnancy and Obstetric Complications in Women
with Autoimmune Diseases
* Section Seven: Vaccination before or during pregnancy
* 7: Cara D Varley and Kevin L Winthrop: Vaccination before or during
pregnancy
* Section Eight: Rare diseases in pregnancy
* 8.1: Karen Schreiber and Monika Ostensen: SLE
* 8.2: Karen Schreiber and Soeren Jacobsen: Systemic lupus
erythematosus and the risk of cardiovascular disease
* 8.3: Karen Schreiber and Savino Sciascia: 3 Antiphospholipid syndrome
* 8.4: Megan Clowse and Jon Golenbiewski: Vasculitis in Pregnancy
* 8.5: Eliza Chakravarty: Systemic sclerosis
* 8.6: Muhammed Shipa and David Isenberg: Myositis and Pregnancy
* 8.7: Monika Østensen: Ankylosing spondylitis in pregnancy
* 1: Monika Østensen: Important points of pre-pregnancy counselling
* Section Two: Patients with pre-pregnancy complications
* 2.1: Andrew James Doyle and Beverley Jane Hunt: Thrombotic
Complications in pregnant patients with rheumatic disease
* 2.2: Roseann O'Doherty and Fionnuala Ní Ainle: Prevention of
postpartum venous thromboembolism (VTE)
* 2.3: Eliza Chakravarty: Pulmonary Arterial Hypertension
* 2.4: Hannah Blakey and Kate Bramham: Advanced renal disease / renal
impairment
* 2.5: Massimo Radin, Karen Schreiber, and Savino Sciascia: Antibodies
as risk factors for adverse maternal and fetal outcomes
* Section Three: Adjustment of therapy before/during pregnancy and
lactation
* 3.1: Monika Østensen and Ian Giles: Disease modifying drugs,
biological drugs and concomitant medications before/during pregnancy
and lactation
* 3.2: Christof Schaefer: Managing a patient exposed to a teratogenic
drug at different stages of pregnancy
* Section Four: Infection during pregnancy
* 4: Maria Rhona G. Bergantin and Sandra V. Navarra: Infection in a
pregnant patient on immunosuppressive treatment
* Section Five: Organ specific flares during pregnancy
* 5: Bonnie L. Bermas and Eliza Chakravarty: Managing Organ Specific
Flares
* Section Six: Obstetric complications in women with autoimmune
diseases
* 6: D. Ware Branch: Pregnancy and Obstetric Complications in Women
with Autoimmune Diseases
* Section Seven: Vaccination before or during pregnancy
* 7: Cara D Varley and Kevin L Winthrop: Vaccination before or during
pregnancy
* Section Eight: Rare diseases in pregnancy
* 8.1: Karen Schreiber and Monika Ostensen: SLE
* 8.2: Karen Schreiber and Soeren Jacobsen: Systemic lupus
erythematosus and the risk of cardiovascular disease
* 8.3: Karen Schreiber and Savino Sciascia: 3 Antiphospholipid syndrome
* 8.4: Megan Clowse and Jon Golenbiewski: Vasculitis in Pregnancy
* 8.5: Eliza Chakravarty: Systemic sclerosis
* 8.6: Muhammed Shipa and David Isenberg: Myositis and Pregnancy
* 8.7: Monika Østensen: Ankylosing spondylitis in pregnancy
* Section One: Counselling
* 1: Monika Østensen: Important points of pre-pregnancy counselling
* Section Two: Patients with pre-pregnancy complications
* 2.1: Andrew James Doyle and Beverley Jane Hunt: Thrombotic
Complications in pregnant patients with rheumatic disease
* 2.2: Roseann O'Doherty and Fionnuala Ní Ainle: Prevention of
postpartum venous thromboembolism (VTE)
* 2.3: Eliza Chakravarty: Pulmonary Arterial Hypertension
* 2.4: Hannah Blakey and Kate Bramham: Advanced renal disease / renal
impairment
* 2.5: Massimo Radin, Karen Schreiber, and Savino Sciascia: Antibodies
as risk factors for adverse maternal and fetal outcomes
* Section Three: Adjustment of therapy before/during pregnancy and
lactation
* 3.1: Monika Østensen and Ian Giles: Disease modifying drugs,
biological drugs and concomitant medications before/during pregnancy
and lactation
* 3.2: Christof Schaefer: Managing a patient exposed to a teratogenic
drug at different stages of pregnancy
* Section Four: Infection during pregnancy
* 4: Maria Rhona G. Bergantin and Sandra V. Navarra: Infection in a
pregnant patient on immunosuppressive treatment
* Section Five: Organ specific flares during pregnancy
* 5: Bonnie L. Bermas and Eliza Chakravarty: Managing Organ Specific
Flares
* Section Six: Obstetric complications in women with autoimmune
diseases
* 6: D. Ware Branch: Pregnancy and Obstetric Complications in Women
with Autoimmune Diseases
* Section Seven: Vaccination before or during pregnancy
* 7: Cara D Varley and Kevin L Winthrop: Vaccination before or during
pregnancy
* Section Eight: Rare diseases in pregnancy
* 8.1: Karen Schreiber and Monika Ostensen: SLE
* 8.2: Karen Schreiber and Soeren Jacobsen: Systemic lupus
erythematosus and the risk of cardiovascular disease
* 8.3: Karen Schreiber and Savino Sciascia: 3 Antiphospholipid syndrome
* 8.4: Megan Clowse and Jon Golenbiewski: Vasculitis in Pregnancy
* 8.5: Eliza Chakravarty: Systemic sclerosis
* 8.6: Muhammed Shipa and David Isenberg: Myositis and Pregnancy
* 8.7: Monika Østensen: Ankylosing spondylitis in pregnancy
* 1: Monika Østensen: Important points of pre-pregnancy counselling
* Section Two: Patients with pre-pregnancy complications
* 2.1: Andrew James Doyle and Beverley Jane Hunt: Thrombotic
Complications in pregnant patients with rheumatic disease
* 2.2: Roseann O'Doherty and Fionnuala Ní Ainle: Prevention of
postpartum venous thromboembolism (VTE)
* 2.3: Eliza Chakravarty: Pulmonary Arterial Hypertension
* 2.4: Hannah Blakey and Kate Bramham: Advanced renal disease / renal
impairment
* 2.5: Massimo Radin, Karen Schreiber, and Savino Sciascia: Antibodies
as risk factors for adverse maternal and fetal outcomes
* Section Three: Adjustment of therapy before/during pregnancy and
lactation
* 3.1: Monika Østensen and Ian Giles: Disease modifying drugs,
biological drugs and concomitant medications before/during pregnancy
and lactation
* 3.2: Christof Schaefer: Managing a patient exposed to a teratogenic
drug at different stages of pregnancy
* Section Four: Infection during pregnancy
* 4: Maria Rhona G. Bergantin and Sandra V. Navarra: Infection in a
pregnant patient on immunosuppressive treatment
* Section Five: Organ specific flares during pregnancy
* 5: Bonnie L. Bermas and Eliza Chakravarty: Managing Organ Specific
Flares
* Section Six: Obstetric complications in women with autoimmune
diseases
* 6: D. Ware Branch: Pregnancy and Obstetric Complications in Women
with Autoimmune Diseases
* Section Seven: Vaccination before or during pregnancy
* 7: Cara D Varley and Kevin L Winthrop: Vaccination before or during
pregnancy
* Section Eight: Rare diseases in pregnancy
* 8.1: Karen Schreiber and Monika Ostensen: SLE
* 8.2: Karen Schreiber and Soeren Jacobsen: Systemic lupus
erythematosus and the risk of cardiovascular disease
* 8.3: Karen Schreiber and Savino Sciascia: 3 Antiphospholipid syndrome
* 8.4: Megan Clowse and Jon Golenbiewski: Vasculitis in Pregnancy
* 8.5: Eliza Chakravarty: Systemic sclerosis
* 8.6: Muhammed Shipa and David Isenberg: Myositis and Pregnancy
* 8.7: Monika Østensen: Ankylosing spondylitis in pregnancy